Shanghai, China In 1999 was created Sincere Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Shanghai. The company was established in Asia in China.
The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2017.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. We can highlight the next thriving fund investment areas, such as Augmented Reality, Software. Among the various public portfolio startups of the fund, we may underline HiScene Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Sincere Capital, startups are often financed by Meitu, GGV Capital, Chuchuang Investment. The meaningful sponsors for the fund in investment in the same round are V Star Capital, Seekdource, Meitu. In the next rounds fund is usually obtained by Yangtze River Delta Collaborative Advantage Industry Fund, Panxi Capital Management, Ondine Capital.
| Fund Name | Location |
| 3G Capital Partners | New York, New York, United States |
| Alfa Ventures | Delhi, Delhi, India |
| Clearbanc | Canada, Ontario, Toronto |
| Danbei Qiye | China, Ningbo, Zhejiang |
| Ellis Accelerator | New York, New York, United States |
| Evok Innovations | British Columbia, Canada, Vancouver |
| First Analysis | Chicago, Illinois, United States |
| GL Capital | China, Shanghai |
| Hokkaido Bank | Hokkaido Prefecture, Japan, Sapporo |
| Hongyou Investment | - |
| Huzhou Quanmei International Trade | China, Huzhou, Zhejiang |
| Kaixuantong Touzi | Beijing, Beijing, China |
| Mountain Cleantech | Baar, Switzerland, Zug |
| MTI | East Sussex, Herstmonceux, United Kingdom |
| NIPR | Kansas City, Missouri, United States |
| PERSOL PROCESS & TECHNOLOGY | Japan, Koto |
| Shannan Youmei Di Touzi Zixun Guanli Co., Ltd. | China, Japan, Kagoshima Prefecture |
| The Sapir Organization | New York, New York, United States |
| Workforce Partners | Connecticut, United States, Wilton |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Laser Link | $15M | 10 Nov 2023 | Shanghai, Shanghai, China | ||
Zenosic | $46M | 06 Sep 2023 | Nanjing, Jiangsu, China | ||
Cullgen | $35M | 08 May 2023 | Ohio, United States | ||
Base Therapeutics | 16 Jan 2023 | Zhuhai, Guangdong, China | |||
Bichen Pharmaceutical | $30M | 04 Jan 2022 | Shanghai, Shanghai, China | ||
Yoguang Technology | 29 Dec 2021 | Haidian, Beijing, China | |||
Hongxin Gases | $15M | 28 Sep 2021 | Fengxian, Jiangsu, China | ||
GeneMind Biosciences | $21M | 01 Sep 2020 | Jiangxi, Guangdong, China | ||
| $278M | 29 Apr 2020 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Laser Link | $15M | 10 Nov 2023 | Shanghai, Shanghai, China | ||
Zenosic | $46M | 06 Sep 2023 | Nanjing, Jiangsu, China | ||
Cullgen | $35M | 08 May 2023 | Ohio, United States | ||
Base Therapeutics | 16 Jan 2023 | Zhuhai, Guangdong, China | |||
Bichen Pharmaceutical | $30M | 04 Jan 2022 | Shanghai, Shanghai, China | ||
Yoguang Technology | 29 Dec 2021 | Haidian, Beijing, China | |||
Hongxin Gases | $15M | 28 Sep 2021 | Fengxian, Jiangsu, China | ||
GeneMind Biosciences | $21M | 01 Sep 2020 | Jiangxi, Guangdong, China | ||
| $278M | 29 Apr 2020 | China, Shanghai |
